Shanghai Pharmaceuticals Holding Co., Ltd (OTCMKTS:SHPMF) Short Interest Update

Shanghai Pharmaceuticals Holding Co., Ltd (OTCMKTS:SHPMFGet Free Report) saw a large increase in short interest during the month of October. As of October 15th, there was short interest totaling 682,600 shares, an increase of 609.6% from the September 30th total of 96,200 shares. Based on an average daily trading volume, of 0 shares, the days-to-cover ratio is presently ∞ days. Based on an average daily trading volume, of 0 shares, the days-to-cover ratio is presently ∞ days.

Shanghai Pharmaceuticals Price Performance

OTCMKTS:SHPMF opened at $1.53 on Tuesday. Shanghai Pharmaceuticals has a 52 week low of $0.99 and a 52 week high of $1.95. The firm’s 50-day simple moving average is $1.53 and its 200 day simple moving average is $1.55.

Shanghai Pharmaceuticals Company Profile

(Get Free Report)

Shanghai Pharmaceuticals Holding Co, Ltd. engages research, development, manufacture, distribution, and retailing of pharmaceutical and healthcare products in China and internationally. The company operates through four segments: Production, Distribution, Retail, and Others. It offers chemicals and biochemicals, Chinese medicines, healthcare products, and medical devices in various therapeutic areas, including digestive system, immune metabolism, motor neuron disease, endocrinology, cardiovascular, psychoneurotic, neoplasm, autoimmunity, systemic anti-infection, mental nerve, anti-tumor, oncology, respiratory system, nervous system, auto-immunity, hypertension, neuromyelitis, diabetes, anticholinesterase, polypeptide hormones uterine tonic, antihistamine, anti-inflammatory, anesthetic, immunomodulatory, antiviral, reflux esophagitis, analgesics, weight management, malignant peritoneal effusion, ulcerative colitis, myasthenia gravis, burn injury, anticoagulant, anti-epileptic, anticonvulsant, Alzheimer’s, and inflammatory bowel diseases.

Further Reading

Receive News & Ratings for Shanghai Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Shanghai Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.